Growth hormone treatment in short children with chronic kidney disease

Growth Hormone Therapy in Pediatrics-20 Years of KIGS

Volumn , Issue , 2007, Pages 407-421

  Mehls, Otto ^a   Lindberg, Anders ^b   Nissel, Richard ^c   Wühl, Elke ^a   Schaefer, Franz ^a   Tönshoff, Burkhard ^a   Haffner, Dieter ^c  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b PFIZER INC   (United States)

^c ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 42049103060     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000101932     Document Type: Chapter

References (77)

1. Wühl E, Mehls O, Schaefer F, ESCAPE Trial Group: Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Kidney Int 2004; 66: 768-776.
2. Wingen AM, Fabian-Bach C, Schaefer F, Mehls O: Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. European Study Group of Nutritional Treatment of Chronic Renal Failure in Childhood. Lancet 1997; 349: 1117-1123.
3. Gorman G, Fivush B, Frankenfield D, Warady B, Watkins S, Brem A, Neu A: Short stature and growth hormone use in pediatric hemodialysis patients. Pediatr Nephrol 2005; 20: 1794-1800.
4. North American Pediatric Renal Transplant Cooperative Study: Annual report.Renal transplantation, dialysis, chronic renal insufficiency. 2006. http://web.emmes.com/study/ped/annlrept/annlrept2006.pdf.
5. Shroff R, Rees L, Trompeter R, Hutchinson C, Ledermann S: Longterm outcome of chronic dialysis children. Pediatr Nephrol 2006; 21: 257-264.
6. Schaefer F, Gilli G, Schärer K: Pubertal growth and final height in chronic renal failure; in Schärer K (ed): Growth and Endocrine Changes in Children and Adolescents with Chronic Renal Failure. Pediatr Adolesc Endocrinol.Basel, Karger, 1989, vol 22, pp 59-69.
7. Hokken-Koelega AC, Van Zaal MA, van Bergen W, de Ridder MA, Stijnen T, Wolff ED, de Jong RC, Donckerwolcke RA, De Muinck Keizer-Schrama SM, Drop SL: Final height and its predictive factors after renal transplantation in childhood. Pediatr Res 1994; 36: 323-328.
8. André JL, Bourquard R, Guillemin F, Krier MJ, Briancon S: Final height in children with chronic renal failure who have not received growth hormone. Pediatr Nephrol 2003; 18: 685-689.
9. Mehls O, Schaefer F, Tönshoff B: Growth Disorders in Chronic Renal Failure. Oxford, Oxford Pharma Genesis Ltd, 2003.
10. Arnold WC, Danford D, Holliday MA: Effects of calorie supplementation on growth in uremia. Kidney Int 1983; 24: 205-209.
11. Wingen AM, Mehls O: Nutrition in children with preterminal chronic renal failure. Myth or important therapeutic aid? Pediatr Nephrol 2002; 17: 111-120.
12. Norman LJ, Macdonald IA, Watson AR: Optimising nutrition in chronic renal insufficiency - growth. Pediatr Nephrol 2004; 19: 1245-1252.
13. Rees L, Shaw V: Nutrition in children with CRF and on dialysis. Pediatr Nephrol DOI: 10.1007/s00467-006-0279-z.
14. Karlberg J, Schaefer F, Hennicke M, Wingen AM, Rigden S, Mehls O: Early age-dependent growth impairment in chronic renal failure. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. Pediatr Nephrol 1996; 10: 283-287.
15. Mehls O, Ritz E, Hunziker EB, Eggli P, Heinrich U, Zapf J: Improvement of growth and food utilization by human recombinant growth hormone in uremia. Kidney Int 1988; 33: 45-52.
16. Samaan NA, Freeman RM: Growth hormone levels in severe renal failure. Metabolism 1970; 19: 102-113.
17. Haffner D, Schaefer F, Girard J, Ritz E, Mehls O: Metabolic clearance of recombinant human growth hormone in health and chronic renal failure. J Clin Invest 1994; 93: 1163-1171.
18. Schaefer F, Veldhuis JD, Jones J, Schärer K: Alterations in growth hormone secretion and clearance in peripubertal boys with chronic renal failure and after renal transplantation. J Clin Endocrinol Metab 1994; 78: 1298-1306.
19. Tönshoff B, Veldhuis JD, Heinrich U, Mehls O: Deconvolution analysis of spontaneous nocturnal growth hormone secretion in prepubertal children with chronic renal failure. Pediatr Res 1995; 37: 86-93.
20. Tönshoff B, Eden S, Weiser E, Carlsson B, Robinson IC, Blum WF, Mehls O: Reduced hepatic growth hormone (GH) receptor gene expression and increased plasma GH binding protein in experimental uremia. Kidney Int 1994; 45: 1085-1092.
21. Tönshoff B, Cronin MJ, Reichert M, Haffner D, Wingen AM, Blum WF, Mehls O: Reduced concentration of serum growth hormone (GH)-binding protein in children with chronic renal failure: correlation with GH insensitivity. J Clin Endocrinol Metab 1997; 82: 1007-1013.
22. Schaefer F, Chen Y, Tsao T, Nouri P, Rabkin R: Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia. J Clin Invest 2001; 108: 467-475.
23. Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, Pratt KL, Bezrodnik L, Jasper H, Tepper A, Heinrich JJ, Rosenfeld RG: Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 2003; 349: 1139-1147.
24. Tönshoff B, Powell DR, Zhao D, Durham SK, Coleman ME, Domene HM, Blum WF, Baxter RC, Moore LC, Kaskel FJ: Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein-1 and -2 gene expression in experimental uremia. Endocrinology 1997; 138: 938-946.
25. Blum WF: Insulin-like growth factors (IGFs) and IGF binding proteins in chronic renal failure: evidence for reduced secretion of IGFs. Acta Paediatr Scand Suppl 1991; 379: 24-31.
26. Ulinski T, Mohan S, Kiepe D, Blum WF, Wingen AM, Mehls O, Tönshoff B: Serum insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 in children with chronic renal failure: relationship to growth and glomerular filtration rate. Pediatr Nephrol 2000; 14:589-597.
27. Tönshoff B, Blum WF, Wingen AM, Mehls O: Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, and 3 in children with chronic renal failure: relationship to height and glomerular filtration rate. J Clin Endocrinol Metab 1995; 80: 2684-2691.
28. Tönshoff B, Blum WF, Mehls O: Serum insulin-like growth factors and their binding proteins in children with endstage renal disease. Pediatr Nephrol 1996; 10: 269-274.
29. Powell DR, Liu F, Baker B, et al: Characterization of insulin-like growth factor binding protein-3 in chronic renal failure serum. Pediatr Res 1993; 33: 136-143.
30. Blum WF, Ranke MB, Kietzmann K, Tönshoff B, Mehls O: Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia. Pediatr Nephrol 1991; 5: 539-544.
31. Mak RH, Pak Y: End-organ resistance to growth hormone and IGF-I in epiphyseal chondrocytes of rats with chronic renal failure. Kidney Int 1996; 50: 400-406.
32. Powell DR, Liu F, Baker BK, et al: Modulation of growth factors by growth hormone in children with chronic renal failure. The Southwest Pediatric Nephrology Study Group. Kidney Int 1997; 51: 1970-1979.
33. Powell DR, Durham SK, Liu F, Baker BK, Lee PD, Watkins SL, Campbell PG, Brewer ED, Hintz RL, Hogg RJ: The insulin-like growth factor axis and growth in children with chronic renal failure: a report of the Southwest Pediatric Nephrology Study Group. J Clin Endocrinol Metab 1998; 83: 1654-1661.
34. Tönshoff B, Mehls O, Heinrich U, Blum WF, Ranke MB, Schauer A: Growthstimulating effects of recombinant human growth hormone in children with end-stage renal disease. J Pediatr 1990; 4: 561-566.
35. Tanner JM, Whitehouse RH: Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976; 51: 170-179.
36. Prader A, Largo RH, Molinari L, Issler C: Physical growth of Swiss children from birth to 20 years of age. First Zürich longitudinal study of growth and development. Helv Paediatr Acta Suppl 1989; 52: 1-125.
37. Mehls O, Berg U, Broyer M, Rizzoni G:Chronic renal failure and growth hormone treatment: review of the literature and experience in KIGS; in Ranke MB, Wilton P (eds): Growth Hormone Therapy in KIGS - 10 Years Experience,ed 1. Heidelberg, Barth, 1999, pp 327-340.
38. Fine RN, Kohaut EC, Brown D, Perlman AJ: Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. Genentech Cooperative Study Group. J Pediatr 1994; 124: 374-382.
39. Vimalachandra D, Hodson EM, Willis NS, Craig JC, Cowell C, Knight JF: Growth hormone for children with chronic kidney disease. Cochrane Database Syst Rev 2006; 3: 1-41.
40. Wühl E, Haffner D, Tönshoff B, Mehls O: Predictors of growth response to rhGH in short children before and after renal transplantation. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Kidney Int Suppl 1993; 43:S76-S82.
41. Haffner D, Wühl E, Schaefer F, Nissel R, Tönshoff B, Mehls O: Factors predictive of the short- and long-term efficacy of growth hormone treatment in prepubertal children with chronic renal failure. German Study Group for Growth Hormone Treatment in Children with Chronic Renal Failure. J Am Soc Nephrol 1998; 9: 1899-1907.
42. Tönshoff B, Haffner D, Albers N, Offner G, Mehls O: Predictors of the response to growth hormone in short prepubertal children post-renal transplant. German Study Group for Growth Hormone Treatment in Children Post Renal Transplantation Study Group Members. Br J Clin Pract Suppl 1996; 85: 34-37.
43. Rees L, Maxwell H: Factors influencing the response to growth hormone in children with renal disease. Pediatr Nephrol 1996; 10: 337-339.
44. Mehls O, Broyer M: Growth response to recombinant human growth hormone in short prepubertal children with chronic renal failure with or without dialysis. The European/Australian Study Group. Acta Paediatr Suppl 1994; 399: 81.
45. Wühl E, Haffner D, Nissel R, Schaefer F, Mehls O: Short dialyzed children respond less to growth hormone than patients prior to dialysis. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Pediatr Nephrol 1996; 10: 294-298.
46. Perfumo F, Verrina E, Edefonti A, Trivelli A, Canepa A, Gusmano R: Is the response to rhGH in peritoneal dialysis patients less effective than in patients with chronic renal insufficiency. Br J Clin Pract Suppl 1996; 85: 18-20.
47. Fischbach M, Terzic J, Menouer S, Dheu C, Soskin S, Helmstetter A, Burger MC: Intensified and daily hemodialysis in children might improve statural growth. Pediatr Nephrol 2006; 21: 1746-1752.
48. Van Es A: Growth hormone treatment in short children with chronic renal failure and after renal transplantation: combined data from European clinical trials. The European Study Group. Acta Paediatr Scand Suppl 1991; 379: 42-48.
49. Haffner D, Schaefer F, Nissel R, Wühl E, Tönshoff B, Mehls O, German Study Group for Growth Hormone Treatment in Chronic Renal Failure: Effect of growth hormone treatment on adult height of children with chronic renal failure. N Engl J Med 2000; 343: 923-930.
50. Ranke MB, Lindberg A: Growth hormone treatment of idiopathic short stature: analysis of the database from KIGS, the Kabi Pharmacia International Growth Study. Acta Paediatr Suppl 1994; 406: 18-23.
51. Hokken-Koelega AC, Stijnen T, de Muinck Keizer-Schrama SM, Wit JM, Wolff ED, de Jong MC, Donckerwolcke RA, Abbad NC, Bot A, Blum WF, et al: Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure. Lancet 1991; 338: 585-590.
52. Hokken-Koelega A, Stijnen T, de Ridder MA, de Muinck Keizer-Schrama SM, Wolff ED, de Jong MC, Donckerwolcke RA, Groothoff JW, Blum WF, Drop SL, et al: Growth hormone treatment in growth-retarded adolescents after renal transplant. Lancet 1994; 343:1313-1317.
53. Haffner D, Schaefer F: Does recombinant growth hormone improve adult height in children with chronic renal failure? Semin Nephrol 2001; 21: 490-497.
54. Fine RN, Stablein D: Long-term use of recombinant human growth hormone in pediatric allograft recipients: a report of the NAPRTCS Transplant Registry.Pediatr Nephrol 2005; 20: 404-408.
55. Crompton CH, Australian and New Zealand Paediatric Nephrology Association: Long-term recombinant human growth hormone use in Australian children with renal disease. Nephrology (Carlton) 2004; 9: 325-330.
56. Hokken-Koelega A, Mulder P, De Jong R, Lilien M, Donckerwolcke R, Groothof J: Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency. Pediatr Nephrol 2000; 14: 701-706.
57. Koller EA, Stadel BV, Malozowski SN: Papilledema in 15 renally compromised patients treated with growth hormone. Pediatr Nephrol 1997; 11: 451-454.
58. Mak RH, Haycock GB, Chantler C: Glucose intolerance in children with chronic renal failure. Kidney Int 1983;24:S22.
59. Shishido S, Sato H, Asanuma H, Shindo M, Hataya H, Ishikura K, Hamasaki Y, Goto M, Ikeda M, Honda M: Unexpectedly high prevalence of pretransplant abnormal glucose tolerance in pediatric kidney transplant recipients. Pediatr Transplant 2006; 10: 67-73.
60. Mehls O, Ritz E, Krempien B, Gilli G,Link K, Willich W, Schärer K: Slipped epiphyses in renal osteodystrophy.Arch Dis Child 1975; 50: 545-554.
61. Mehls O, Ritz E, Oppermann HC, Guignard JP: Femoral head necrosis in uremic children without steroid treatment or transplantation. J Pediatr 1981; 6:926-929.
62. Tönshoff B, Heinrich U, Mehls O: How safe is the treatment of uraemic children with recombinant human growth hormone? Pediatr Nephrol 1991; 5: 454-460.
63. Fine RN, Ho M, Tejani A, Blethen S:Adverse events with rhGH treatment of patients with chronic renal insufficiency and end-stage renal disease. J Pediatr 2003; 142: 539-545.
64. Haffner D, Nissel R, Wühl E, Schaefer F, Bettendorf M, Tönshoff B, Mehls O: Metabolic effects of long-term growth hormone treatment in prepubertal children with chronic renal failure and after kidney transplantation. Pediatr Res 1997; 43: 209-215.
65. Wühl E, Haffner D, Offner G, Broyer M, van't Hoff WG, Mehls O, European Study Group on Growth Hormone Treatment in Children with Nephropathic Cystinosis: Long-term treatment with growth hormone in short children with nephropathic cystinosis. J Pediatr 2001; 138: 880-887.
66. Wühl E, Haffner D, Gretz N, Offner G,van't Hoff WG, Broyer M, Mehls O, The European Study Group on Growth Hormone Treatment in Short Children with Nephropathic Cystinosis: Treatment with recombinant human growth hormone in short children with nephropathic cystinosis: no evidence for increased deterioration rate of renal function. Pediatr Res 1998; 43: 484-488.
67. Haffner D, Zacharewicz S, Mehls O,Heinrich U, Ritz E: The acute effect of growth hormone on GFR is obliterated in chronic renal failure. Clin Nephrol 1989; 32: 266-269.
68. Fine RN, Kohaut E, Brown D, Kuntze J,Attie KM: Long-term treatment of growth retarded children with chronic renal insufficiency, with recombinant human growth hormone. Kidney Int 1996; 49: 781-785.
69. Melk A, Daniel V, Mehls O, Opelz G,Tönshoff B: Longitudinal analysis of Thelper cell phenotypes in renal-transplant recipients undergoing growth hormone therapy. Transplantation 2004; 78: 1792-1801.
70. Fine RN, Yadin O, Nelson PA, Pyke-Grimm K, Boechat MI, Lippe BH, Sherman BM, Ettenger RB, Kamil E: Recombinant human growth hormone treatment of children following renal transplantation. Pediatr Nephrol 1991;5: 147-151.
71. van Dop C, Jabs KL, Donohue PA, Bock GH, Fivush BA, Harmon WE: Accelerated growth rates in children treated with growth hormone after renal transplantation.J Pediatr 1992; 120: 244-250.
72. Hokken-Koelega AC, Stijnen T, de Jong RC, Donckerwolcke RA, Groothoff JW,Wolff ED, Blum WF, de Munick Keizer-Schrama SM: A placebo-controlled,double-blind trial of growth hormone treatment in prepubertal children after renal transplant. Kidney Int Suppl 1996; 53:S128-S134.
73. Guest G, Berard E, Crosnier H, Chevallier T, Rappaport R, Broyer M: Effects of growth hormone in short children after renal transplantation. Pediatr Nephrol 1998; 12: 437-446.
74. Fine RN, Stablein D, Cohen AH, Tejani A, Kohaut E: Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS. Kidney Int 2002; 62: 688-696.
75. Watkins SL: Is severe renal osteodystrophy a contraindication for recombinant human growth hormone treatment? Pediatr Nephrol 1996; 10: 351.
76. Boechat M, Winters W, Hogg R, Fine RN, Watkins S: Avascular necrosis of the femoral head in children with chronic renal disease. Radiology 2001; 218: 411-413.
77. Picca S, Cappa M, Martinez C, Moges SI, Osborn J, Perfumo F, Ardissino G,Bonaudo R, Montini G, Rizzoni G:Parathyroid hormone levels in pubertal uremic adolescents treated with growth hormone. Pediatr Nephrol 2004; 19: 71-76.